Adage Capital Partners
IPSC icon

Adage Capital Partners’s Century Therapeutics IPSC Stock Holding History

Adage Capital Partners’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.28M Hold
3,789,538
– – 0.01% 736
2026
Q1 		$8.56M Buy
3,789,538
+1,950,838
+106% +$4.1M 0.01% 723
2025
Q4 		$1.83M Buy
+1,838,700
New +$1.12M ﹤0.01% 844
2024
Q4 		– Sell
-1,322,751
Closed -$2.26M – 920
2024
Q3 		$2.26M Hold
1,322,751
– – ﹤0.01% 778
2024
Q2 		$3.37M Buy
+1,322,751
New +$4.18M 0.01% 747

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Adage Capital Partners's IPSC Position: Q2 2026 in Review

Adage Capital Partners held its Century Therapeutics (IPSC) position steady in Q2 2026 at 3,789,538 shares worth $9.28M. The position accounts for 0.01% of the portfolio, ranked #736.

Adage Capital Partners first reported a position in IPSC in Q2 2024 and has held it in 5 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Adage Capital Partners held 3,789,538 shares of Century Therapeutics worth $9.28M as of Q2 2026.
  • Adage Capital Partners left its Century Therapeutics share count unchanged in Q2 2026.
  • Century Therapeutics made up 0.01% of Adage Capital Partners's portfolio in Q2 2026, its #736 holding.
  • Adage Capital Partners first reported a position in Century Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.